Moors & Cabot Inc. Sells 322 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Moors & Cabot Inc. lessened its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 1.1% during the second quarter, HoldingsChannel reports. The firm owned 29,041 shares of the financial services provider’s stock after selling 322 shares during the period. Moors & Cabot Inc.’s holdings in iShares Biotechnology ETF were worth $3,986,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently modified their holdings of IBB. Blue Fin Capital Inc. grew its position in shares of iShares Biotechnology ETF by 0.7% during the 2nd quarter. Blue Fin Capital Inc. now owns 10,516 shares of the financial services provider’s stock valued at $1,443,000 after purchasing an additional 74 shares in the last quarter. Crewe Advisors LLC grew its position in shares of iShares Biotechnology ETF by 42.9% during the 4th quarter. Crewe Advisors LLC now owns 260 shares of the financial services provider’s stock valued at $35,000 after purchasing an additional 78 shares in the last quarter. Main Street Financial Solutions LLC grew its position in shares of iShares Biotechnology ETF by 1.0% during the 2nd quarter. Main Street Financial Solutions LLC now owns 8,002 shares of the financial services provider’s stock valued at $1,098,000 after purchasing an additional 82 shares in the last quarter. Perkins Coie Trust Co grew its position in shares of iShares Biotechnology ETF by 0.3% during the 2nd quarter. Perkins Coie Trust Co now owns 25,184 shares of the financial services provider’s stock valued at $3,457,000 after purchasing an additional 83 shares in the last quarter. Finally, HCR Wealth Advisors grew its position in shares of iShares Biotechnology ETF by 0.6% during the 2nd quarter. HCR Wealth Advisors now owns 13,453 shares of the financial services provider’s stock valued at $1,847,000 after purchasing an additional 83 shares in the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 0.2 %

Shares of NASDAQ:IBB opened at $148.09 on Tuesday. iShares Biotechnology ETF has a 52-week low of $111.83 and a 52-week high of $150.17. The firm has a fifty day moving average of $145.10 and a 200 day moving average of $138.27.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.